Generating evidence for therapeutic effects: the need for well-conducted randomized trials.
Publication
, Journal Article
Califf, RM; Curtis, LH; Harrington, RA; Hernandez, AF; Peterson, ED
Published in: J Clin Invest
January 19, 2021
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Clin Invest
DOI
EISSN
1558-8238
Publication Date
January 19, 2021
Volume
131
Issue
2
Location
United States
Related Subject Headings
- Randomized Controlled Trials as Topic
- Practice Guidelines as Topic
- Myocardial Infarction
- Immunology
- Humans
- COVID-19
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 31 Biological sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Califf, R. M., Curtis, L. H., Harrington, R. A., Hernandez, A. F., & Peterson, E. D. (2021). Generating evidence for therapeutic effects: the need for well-conducted randomized trials. J Clin Invest, 131(2). https://doi.org/10.1172/JCI146391
Califf, Robert M., Lesley H. Curtis, Robert A. Harrington, Adrian F. Hernandez, and Eric D. Peterson. “Generating evidence for therapeutic effects: the need for well-conducted randomized trials.” J Clin Invest 131, no. 2 (January 19, 2021). https://doi.org/10.1172/JCI146391.
Califf RM, Curtis LH, Harrington RA, Hernandez AF, Peterson ED. Generating evidence for therapeutic effects: the need for well-conducted randomized trials. J Clin Invest. 2021 Jan 19;131(2).
Califf, Robert M., et al. “Generating evidence for therapeutic effects: the need for well-conducted randomized trials.” J Clin Invest, vol. 131, no. 2, Jan. 2021. Pubmed, doi:10.1172/JCI146391.
Califf RM, Curtis LH, Harrington RA, Hernandez AF, Peterson ED. Generating evidence for therapeutic effects: the need for well-conducted randomized trials. J Clin Invest. 2021 Jan 19;131(2).
Published In
J Clin Invest
DOI
EISSN
1558-8238
Publication Date
January 19, 2021
Volume
131
Issue
2
Location
United States
Related Subject Headings
- Randomized Controlled Trials as Topic
- Practice Guidelines as Topic
- Myocardial Infarction
- Immunology
- Humans
- COVID-19
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 31 Biological sciences
- 11 Medical and Health Sciences